| Filed On | Filing |
|---|---|
| 09 Oct 2026 | SCHEDULE 13D |
| 09 Oct 2026 |
Form 3: Zhou Ming, Director
Holds 20,000,000 shares of Common Stock |
| 09 Oct 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
On October 8, 2026, the board of directors of Goldenwell Biotech, Inc. (the “Company”) appointed Ming Zhou as a director. The board of directors now consists of four persons, including Shuang Liu, Yang Lee, Hua Xie and Ms. Zhou. |
| 29 Sep 2026 |
8-K: Changes in Registrant's Certifying Accountant
We have read Goldenwell Biotech, Inc’s statements included under Item 4.01 of its Form 8-K dated September 28, 2026. We agree with the statements concerning our firm under Items 4.01. |
| 14 Aug 2026 | FORM 10-Q |
| 01 Jul 2026 | FORM 10-K |
| 01 Jul 2026 | FORM 10-Q |
| 29 Jun 2026 | FORM 10-Q/A |
| 26 Jun 2026 | FORM 10-Q/A |
| 26 Jun 2026 | FORM 10-Q/A |
| 27 May 2026 | 8-K: Non-Reliance on Previously Issued Financial Statements |
| 12 May 2026 | NT 10-Q |
| 31 Mar 2026 | NT 10-K |
| 08 Dec 2025 | FORM 10-Q |
| 12 Sep 2025 | FORM 10-Q |
| 19 Aug 2025 | 8-K: Changes in Registrant's Certifying Accountant |
| 14 Aug 2025 | NT 10-Q |
| 27 May 2025 | FORM 10-Q |
| 15 May 2025 | FORM 10-K |
| 14 May 2025 | FORM NT 10-Q |
Loading...
